387 related articles for article (PubMed ID: 21632503)
1. Beta blockers and breast cancer mortality: a population- based study.
Barron TI; Connolly RM; Sharp L; Bennett K; Visvanathan K
J Clin Oncol; 2011 Jul; 29(19):2635-44. PubMed ID: 21632503
[TBL] [Abstract][Full Text] [Related]
2. Expanding our therapeutic options: Beta blockers for breast cancer?
Ganz PA; Cole SW
J Clin Oncol; 2011 Jul; 29(19):2612-6. PubMed ID: 21632500
[No Abstract] [Full Text] [Related]
3. The relation of reproductive factors to mortality from breast cancer.
Daling JR; Malone KE; Doody DR; Anderson BO; Porter PL
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):235-41. PubMed ID: 11895871
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
Bradbury BD; Lash TL; Kaye JA; Jick SS
Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
[TBL] [Abstract][Full Text] [Related]
5. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
Wärnberg F; Bergh J; Zack M; Holmberg L
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):495-9. PubMed ID: 11352860
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant supplements and risk of breast cancer recurrence and breast cancer-related mortality among postmenopausal women.
Fleischauer AT; Simonsen N; Arab L
Nutr Cancer; 2003; 46(1):15-22. PubMed ID: 12925299
[TBL] [Abstract][Full Text] [Related]
8. Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer.
Sarp S; Fioretta G; Verkooijen HM; Vlastos G; Rapiti E; Schubert H; Sappino AP; Bouchardy C
Ann Surg Oncol; 2007 Mar; 14(3):1031-9. PubMed ID: 17176985
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.
Trivers KF; Gammon MD; Abrahamson PE; Lund MJ; Flagg EW; Moorman PG; Kaufman JS; Cai J; Porter PL; Brinton LA; Eley JW; Coates RJ
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1822-7. PubMed ID: 17855700
[TBL] [Abstract][Full Text] [Related]
10. Is Beta-Blocker Use Beneficial in Breast Cancer? A Meta-Analysis.
Kim HY; Jung YJ; Lee SH; Jung HJ; Pak K
Oncology; 2017; 92(5):264-268. PubMed ID: 28132057
[TBL] [Abstract][Full Text] [Related]
11. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis.
Rapiti E; Verkooijen HM; Vlastos G; Fioretta G; Neyroud-Caspar I; Sappino AP; Chappuis PO; Bouchardy C
J Clin Oncol; 2006 Jun; 24(18):2743-9. PubMed ID: 16702580
[TBL] [Abstract][Full Text] [Related]
12. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
[TBL] [Abstract][Full Text] [Related]
13. Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS).
Chan JD; Rea TD; Smith NL; Siscovick D; Heckbert SR; Lumley T; Chaves P; Furberg CD; Kuller L; Psaty BM
Am Heart J; 2005 Sep; 150(3):464-70. PubMed ID: 16169325
[TBL] [Abstract][Full Text] [Related]
14. Topical beta-blockers and mortality.
Müskens RP; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
Ophthalmology; 2008 Nov; 115(11):2037-43. PubMed ID: 18801580
[TBL] [Abstract][Full Text] [Related]
15. Mortality impact of less-than-standard therapy in older breast cancer patients.
Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
[TBL] [Abstract][Full Text] [Related]
16. A population-based analysis of the class effect of beta-blockers after myocardial infarction.
Rinfret S; Abrahamowicz M; Tu J; Humphries K; Eisenberg MJ; Richard H; Austin PC; Pilote L
Am Heart J; 2007 Feb; 153(2):224-30. PubMed ID: 17239680
[TBL] [Abstract][Full Text] [Related]
17. β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Hicks BM; Murray LJ; Powe DG; Hughes CM; Cardwell CR
Ann Oncol; 2013 Dec; 24(12):3100-6. PubMed ID: 24050955
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
[TBL] [Abstract][Full Text] [Related]
19. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
Punda A; Polić S; Rumboldt Z; Bagatin J; Marković V; Lukin A
Croat Med J; 2005 Apr; 46(2):219-24. PubMed ID: 15849842
[TBL] [Abstract][Full Text] [Related]
20. A case-control study of hormone replacement therapy after primary surgical breast cancer treatment.
Ursic-Vrscaj M; Bebar S
Eur J Surg Oncol; 1999 Apr; 25(2):146-51. PubMed ID: 10218456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
